$ISIS Recent News 5 companies that will benefit from

New Post Public Reply Private Reply Replies (0) Message Board

Aug 31, 2014 at 12:42 PM

$ISIS Recent News

5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
Investors blow on the dice as Iraq and the Fed shake up markets 9:09 a.m. June 16, 2014 - Shawn Langlois
S&P, Dow pull in from latest record highs 11:10 a.m. June 2, 2014 - Michael Ashbaugh
Health-care-related stocks keep on giving 1:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 1:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 12:59 p.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 11:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 3:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 10:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 11:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 11:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 3:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 11:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 5:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 6:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 7:26 p.m. June 24, 2013 - Russ Britt
3 ways to play the biotech boom 7:01 a.m. June 3, 2013 - Jeff Reeves
S&P 500 holds the 50-day average — barely 11:41 a.m. April 18, 2013 - Michael Ashbaugh
Biogen inks drug-development deal with Isis 3:06 p.m. Dec. 10, 2012 - MarketWatch.com

Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog 4:55 p.m. Aug. 29, 2014 - Zacks.com
Biotech Stocks 101 — What Investors Need to Know 6:59 a.m. Aug. 29, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – LCI ISIS CNC ACHN 8:00 a.m. Aug. 28, 2014 - InvestorPlace.com
Companies With 'ISIS' Name Get Unwanted Attention 3:06 p.m. Aug. 27, 2014 - FOXBusiness
Isis Pharmaceuticals, Inc. (ISIS) Surges: Stock Moves 10.8% Higher - Tale of the Tape 9:11 a.m. Aug. 27, 2014 - Zacks.com
CNBC's Stock Pops & Drops From August 26 7:16 p.m. Aug. 26, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – ISIS THRX EXAS CBPO 6:00 a.m. Aug. 26, 2014 - InvestorPlace.com
Fast Money Picks For August 26 7:03 p.m. Aug. 25, 2014 - benzinga.com
Hottest Healthcare Stocks Now – PBYI ISIS EXAS IMGN 8:30 a.m. Aug. 25, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – PRGO WX ISIS TARO 8:30 a.m. Aug. 14, 2014 - InvestorPlace.com
UPDATE: Laidlow & Co. Initiates Coverage on Isis Pharmaceuticals, Inc. at Buy, Announces $52.00 PT 10:34 a.m. Aug. 12, 2014 - benzinga.com
Alnylam Pharmaceuticals Has Plenty On Its Plate 10:36 a.m. Aug. 9, 2014 - Seeking Alpha
Isis Pharmaceuticals Posts Narrower-Than-Expected Q2 Loss - Analyst Blog 9:10 a.m. Aug. 7, 2014 - Zacks.com
Isis Pharmaceuticals, Inc. (ISIS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 7, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – CBPO ISIS HAE LPNT 2:00 p.m. Aug. 5, 2014 - InvestorPlace.com
Company News for August 05, 2014 - Corporate Summary 10:10 a.m. Aug. 5, 2014 - Zacks.com
ISIS Pharmaceuticals' (ISIS) CEO Stan Crooke on Q2 2014 Results - Earnings Call Transcript 4:24 p.m. Aug. 4, 2014 - Seeking Alpha
10-Q: ISIS PHARMACEUTICALS INC 3:29 p.m. Aug. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biggest Movers in Healthcare Stocks Now – ALNY ISIS INCY HTWR 1:15 p.m. Aug. 4, 2014 - InvestorPlace.com
Insider Trading Alert - GPN, UHS And ISIS Traded By Insiders 10:30 a.m. Aug. 4, 2014 - TheStreet.com

Upcoming Conferences Schedule, Clinical Trial Data Release Schedule, Milestone Payment, and Expansion of Partnership - Research Reports on Celgene, Actavis, Regeneron, ISIS and UnitedHealth 9:10 a.m. Aug. 29, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-APOCIII Rx in Patients with FCS 7:00 a.m. Aug. 28, 2014 - PR Newswire - PRF
Orphan Diseases Partnering Terms and Agreements 9:10 p.m. Aug. 27, 2014 - PR Newswire - PRF
Critical Alerts For Arrowhead Research, Isis Pharmaceuticals, MobileIron, JP Morgan Chase and Viacom Released By InvestorsObserver 9:31 a.m. Aug. 27, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy 7:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 9:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals, Amgen, and Discover Financial Services Released By InvestorsObserver 9:31 a.m. Aug. 8, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 7:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 7:00 a.m. July 28, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-APO(a) Rx in Patients with High Lp(a) 7:00 a.m. July 17, 2014 - PR Newswire - PRF
Critical Alerts For Cninsure, Freeport-McMoRan, Level 3 Communications, Electronic Arts, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 16, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx 7:00 a.m. July 16, 2014 - PR Newswire - PRF
Type 2 Diabetes Global Clinical Trials Review, H1, 2014 3:31 p.m. July 15, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics 7:04 a.m. July 14, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program 7:00 a.m. July 2, 2014 - PR Newswire - PRF
Critical Alerts For General Electric, Deere, Isis Pharmaceuticals, Expedia, and Sears Holdings Released By InvestorsObserver 9:31 a.m. June 26, 2014 - PR Newswire - PRF
Global Diabetic Retinopathy Market 2014-2018 12:22 p.m. June 25, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million From GSK for Advancing ISIS-TTR Rx 7:00 a.m. June 24, 2014 - PR Newswire - PRF
Collaborations, FDA Clearances, and Technical Updates - Analyst Notes on Isis Pharmaceuticals, DexCom, Theravance Biopharma, Intrexon and Alere 5:30 a.m. June 19, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

PureHealth's Acid Reflux Solutions: An Investor's Insight

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

SMPL Faces Legal Drama: What Investors Need to Know

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

D-Wave Faces Legal Questions After CFO Exit and Losses

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Protecting Teeth: Insights from Endodontist Dr. Joubert

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...